CN101028297A - 一种治疗肝腹水的中药 - Google Patents
一种治疗肝腹水的中药 Download PDFInfo
- Publication number
- CN101028297A CN101028297A CN 200610164309 CN200610164309A CN101028297A CN 101028297 A CN101028297 A CN 101028297A CN 200610164309 CN200610164309 CN 200610164309 CN 200610164309 A CN200610164309 A CN 200610164309A CN 101028297 A CN101028297 A CN 101028297A
- Authority
- CN
- China
- Prior art keywords
- chinese medicine
- hepatic
- quel
- treating
- ganoderma
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000003814 drug Substances 0.000 title claims abstract description 15
- 230000002440 hepatic effect Effects 0.000 title claims description 9
- 241000123113 Phellinus igniarius Species 0.000 claims description 11
- 241001149422 Ganoderma applanatum Species 0.000 claims description 10
- 240000008397 Ganoderma lucidum Species 0.000 claims description 10
- 235000001637 Ganoderma lucidum Nutrition 0.000 claims description 10
- 241001619461 Poria <basidiomycete fungus> Species 0.000 claims description 10
- 206010003445 Ascites Diseases 0.000 claims description 9
- 239000002994 raw material Substances 0.000 claims description 3
- 241000222336 Ganoderma Species 0.000 abstract 1
- 244000248825 Peltandra virginica Species 0.000 abstract 1
- 235000001188 Peltandra virginica Nutrition 0.000 abstract 1
- 241000123107 Phellinus Species 0.000 abstract 1
- 235000008599 Poria cocos Nutrition 0.000 abstract 1
- 239000000463 material Substances 0.000 abstract 1
- 210000004185 liver Anatomy 0.000 description 6
- 230000000694 effects Effects 0.000 description 4
- 241000699670 Mus sp. Species 0.000 description 3
- 206010033557 Palpitations Diseases 0.000 description 3
- 235000009508 confectionery Nutrition 0.000 description 3
- 210000000952 spleen Anatomy 0.000 description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 3
- 206010012735 Diarrhoea Diseases 0.000 description 2
- 208000032843 Hemorrhage Diseases 0.000 description 2
- 206010062717 Increased upper airway secretion Diseases 0.000 description 2
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 2
- 230000001093 anti-cancer Effects 0.000 description 2
- 206010003549 asthenia Diseases 0.000 description 2
- 230000000740 bleeding effect Effects 0.000 description 2
- 239000008280 blood Substances 0.000 description 2
- 210000004369 blood Anatomy 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 208000006454 hepatitis Diseases 0.000 description 2
- 206010022437 insomnia Diseases 0.000 description 2
- 231100000252 nontoxic Toxicity 0.000 description 2
- 230000003000 nontoxic effect Effects 0.000 description 2
- 208000026435 phlegm Diseases 0.000 description 2
- 230000001737 promoting effect Effects 0.000 description 2
- 230000001629 suppression Effects 0.000 description 2
- OILXMJHPFNGGTO-UHFFFAOYSA-N (22E)-(24xi)-24-methylcholesta-5,22-dien-3beta-ol Natural products C1C=C2CC(O)CCC2(C)C2C1C1CCC(C(C)C=CC(C)C(C)C)C1(C)CC2 OILXMJHPFNGGTO-UHFFFAOYSA-N 0.000 description 1
- RQOCXCFLRBRBCS-UHFFFAOYSA-N (22E)-cholesta-5,7,22-trien-3beta-ol Natural products C1C(O)CCC2(C)C(CCC3(C(C(C)C=CCC(C)C)CCC33)C)C3=CC=C21 RQOCXCFLRBRBCS-UHFFFAOYSA-N 0.000 description 1
- HZLCGUXUOFWCCN-UHFFFAOYSA-N 2-hydroxynonadecane-1,2,3-tricarboxylic acid Chemical compound CCCCCCCCCCCCCCCCC(C(O)=O)C(O)(C(O)=O)CC(O)=O HZLCGUXUOFWCCN-UHFFFAOYSA-N 0.000 description 1
- OQMZNAMGEHIHNN-UHFFFAOYSA-N 7-Dehydrostigmasterol Natural products C1C(O)CCC2(C)C(CCC3(C(C(C)C=CC(CC)C(C)C)CCC33)C)C3=CC=C21 OQMZNAMGEHIHNN-UHFFFAOYSA-N 0.000 description 1
- 206010002383 Angina Pectoris Diseases 0.000 description 1
- 201000009030 Carcinoma Diseases 0.000 description 1
- 208000017897 Carcinoma of esophagus Diseases 0.000 description 1
- 206010008909 Chronic Hepatitis Diseases 0.000 description 1
- 206010011224 Cough Diseases 0.000 description 1
- 102000018832 Cytochromes Human genes 0.000 description 1
- 108010052832 Cytochromes Proteins 0.000 description 1
- DNVPQKQSNYMLRS-NXVQYWJNSA-N Ergosterol Natural products CC(C)[C@@H](C)C=C[C@H](C)[C@H]1CC[C@H]2C3=CC=C4C[C@@H](O)CC[C@]4(C)[C@@H]3CC[C@]12C DNVPQKQSNYMLRS-NXVQYWJNSA-N 0.000 description 1
- 206010019851 Hepatotoxicity Diseases 0.000 description 1
- 208000031226 Hyperlipidaemia Diseases 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- 208000009525 Myocarditis Diseases 0.000 description 1
- 208000007443 Neurasthenia Diseases 0.000 description 1
- 206010030113 Oedema Diseases 0.000 description 1
- 206010030155 Oesophageal carcinoma Diseases 0.000 description 1
- 206010030302 Oliguria Diseases 0.000 description 1
- 208000002193 Pain Diseases 0.000 description 1
- 206010061902 Pancreatic neoplasm Diseases 0.000 description 1
- 208000004880 Polyuria Diseases 0.000 description 1
- 208000028872 Progressive muscular dystrophy Diseases 0.000 description 1
- 208000025747 Rheumatic disease Diseases 0.000 description 1
- 206010039491 Sarcoma Diseases 0.000 description 1
- 208000007107 Stomach Ulcer Diseases 0.000 description 1
- 208000025865 Ulcer Diseases 0.000 description 1
- 208000012886 Vertigo Diseases 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 229940040563 agaric acid Drugs 0.000 description 1
- 230000036528 appetite Effects 0.000 description 1
- 235000019789 appetite Nutrition 0.000 description 1
- 208000006673 asthma Diseases 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000001914 calming effect Effects 0.000 description 1
- 208000019425 cirrhosis of liver Diseases 0.000 description 1
- 230000001276 controlling effect Effects 0.000 description 1
- 208000029078 coronary artery disease Diseases 0.000 description 1
- 206010061428 decreased appetite Diseases 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 238000007599 discharging Methods 0.000 description 1
- 230000035619 diuresis Effects 0.000 description 1
- 208000000718 duodenal ulcer Diseases 0.000 description 1
- 201000006549 dyspepsia Diseases 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- DNVPQKQSNYMLRS-SOWFXMKYSA-N ergosterol Chemical compound C1[C@@H](O)CC[C@]2(C)[C@H](CC[C@]3([C@H]([C@H](C)/C=C/[C@@H](C)C(C)C)CC[C@H]33)C)C3=CC=C21 DNVPQKQSNYMLRS-SOWFXMKYSA-N 0.000 description 1
- 201000005619 esophageal carcinoma Diseases 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 230000006870 function Effects 0.000 description 1
- 230000002496 gastric effect Effects 0.000 description 1
- 210000001035 gastrointestinal tract Anatomy 0.000 description 1
- 208000035861 hematochezia Diseases 0.000 description 1
- 230000023597 hemostasis Effects 0.000 description 1
- 231100000283 hepatitis Toxicity 0.000 description 1
- 231100000304 hepatotoxicity Toxicity 0.000 description 1
- 230000007686 hepatotoxicity Effects 0.000 description 1
- 230000000968 intestinal effect Effects 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 201000002364 leukopenia Diseases 0.000 description 1
- 231100001022 leukopenia Toxicity 0.000 description 1
- 210000004072 lung Anatomy 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 206010025482 malaise Diseases 0.000 description 1
- 208000015486 malignant pancreatic neoplasm Diseases 0.000 description 1
- 210000004914 menses Anatomy 0.000 description 1
- 201000006417 multiple sclerosis Diseases 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 231100000614 poison Toxicity 0.000 description 1
- 208000008128 pulmonary tuberculosis Diseases 0.000 description 1
- 230000008929 regeneration Effects 0.000 description 1
- 238000011069 regeneration method Methods 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 230000000552 rheumatic effect Effects 0.000 description 1
- 230000000630 rising effect Effects 0.000 description 1
- 230000004206 stomach function Effects 0.000 description 1
- 238000005728 strengthening Methods 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 239000003440 toxic substance Substances 0.000 description 1
- 230000002936 tranquilizing effect Effects 0.000 description 1
- DCXXMTOCNZCJGO-UHFFFAOYSA-N tristearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(OC(=O)CCCCCCCCCCCCCCCCC)COC(=O)CCCCCCCCCCCCCCCCC DCXXMTOCNZCJGO-UHFFFAOYSA-N 0.000 description 1
- 231100000397 ulcer Toxicity 0.000 description 1
- 231100000889 vertigo Toxicity 0.000 description 1
- 210000001835 viscera Anatomy 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
本发明涉及一种治疗肝腹水的中药。其特征在于：该中药药材原料的重量配比组成为为赤芝5～50、桑黄5～100、树舌5～100、茯苓5～100。各组分的最佳重量配比为赤芝20、桑黄60、树舌40、茯苓50。水煎，日服1次；对治肝硬化有明显疗效。
Description
技术领域
本发明涉及一种治疗肝腹水的中药。
背景技术
目前，国内治疗肝腹水方面的药物很多，但在中药中，治疗效果很好的中药很少，不能达到治疗与功能恢复相结合的治疗效果。本发明希望找到一条治疗肝腹水方面比较好的药物。
发明内容
本发明的目的是提供一种治疗肝腹水的中药。
本发明中药药材原料的重量配比组成为为赤芝5～50、桑黄5～100、树舌5～100、茯苓5～100。各组分的最佳重量配比为赤芝20、桑黄60、树舌40、茯苓50。
赤芝：甘，淡，味苦，平，无毒。能补肺益肾，和胃健脾，安神定志，扶正培本。用治虚劳咳喘、心悸失眠、食欲不振，近年来用于治疗冠心病、心绞痛、高血压、高血脂症、心肌炎、白细胞减少症、肝炎、胃及十二指肠溃疡、糖尿病、进行性肌营养不良、多发性硬化症等症。有保肝与解毒作用，(1)对sGPT的升高及肝脏三酰甘油的蓄积具有明显的降低作用；(2)能减轻对肝脏毒性的药物毒性作用；(3)促进部分切除肝脏小鼠的肝脏再生修复；(4)可使肝匀浆中细胞色素含量明显的免疫恢复作用。
桑黄(《药性论》)，甘，辛，平，无毒。能清热解毒，收敛止血，利五脏，宣肠气。适用于崩漏带下、血淋、脱肛、肠风下血、妇人劳损等。桑黄子实体具有很好的抗癌活性，含落叶松蕈酸、麦角甾醇等，热水提取物对小白鼠肉瘤S-180的抑制率为96.7％，对小白鼠艾氏癌的抑制率为87％。
树舌：微苦，平。能祛风除湿，清热止痛，止血化痰，消食化积，抗癌。民间多用于治疗急性慢性肝炎、食道癌、胰腺癌、消化道溃疡、早期肝硬化，也可用于治疗肠风泻血、热积胸膈、神经衰弱、消化不良、风湿性肺结核、并有滋补强身功效。
茯苓：性平，味甘淡。利水渗湿，健脾宁心。用于水肿尿少，痰饮眩悸，脾虚食少，便溏泄泻，心神不宁，惊悸失眠。
本发明的目的是这样实现的：
所述各组分的重量配比为为赤芝5～50、桑黄5～100、树舌5～100、茯苓5～100。所述各组分的最佳重量配比为赤芝20、桑黄60、树舌40、茯苓50。
将为赤芝5～50、桑黄5～100、树舌5～100、茯苓5～100剪碎，水煎，日服1次；对治肝腹水有明显疗效。
本发明的有益效果是：原料简单，有效的治肝腹水等症。
具体实施方式
取赤芝20g、桑黄60g、树舌40g、茯苓50g剪碎，加500g水煎到150g水左右服用，日服1次。
取赤芝15g、桑黄40g、树舌25g、茯苓30g剪碎，加500g水煎到150g水左右服用，日服1次。
Claims (2)
1、一种治疗肝腹水的中药，其特征在于：该中药药材原料的重量配比组成为赤芝5～50、桑黄5～100、树舌5～100、茯苓5～100。
2、根据权利要求1所述治疗肝腹水的中药，其特征在于：各组分的最佳重量配比为赤芝20、桑黄60、树舌40、茯苓50。
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 200610164309 CN101028297A (zh) | 2006-11-28 | 2006-11-28 | 一种治疗肝腹水的中药 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 200610164309 CN101028297A (zh) | 2006-11-28 | 2006-11-28 | 一种治疗肝腹水的中药 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN101028297A true CN101028297A (zh) | 2007-09-05 |
Family
ID=38713948
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN 200610164309 Pending CN101028297A (zh) | 2006-11-28 | 2006-11-28 | 一种治疗肝腹水的中药 |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN101028297A (zh) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104887769A (zh) * | 2015-06-01 | 2015-09-09 | 徐艳 | 一种用于治疗肝腹水的药物 |
| CN105194530A (zh) * | 2014-06-19 | 2015-12-30 | 姚本学 | 一种治疗肝腹水的中药制剂 |
-
2006
- 2006-11-28 CN CN 200610164309 patent/CN101028297A/zh active Pending
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105194530A (zh) * | 2014-06-19 | 2015-12-30 | 姚本学 | 一种治疗肝腹水的中药制剂 |
| CN104887769A (zh) * | 2015-06-01 | 2015-09-09 | 徐艳 | 一种用于治疗肝腹水的药物 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN105233202A (zh) | 治疗消化性溃疡药物的制备方法及该方法制备的提取物 | |
| CN101028297A (zh) | 一种治疗肝腹水的中药 | |
| CN101028334A (zh) | 一种治疗慢性扁桃体炎的中药 | |
| CN1555829A (zh) | 一种治疗癌症的中药制剂 | |
| CN101028306A (zh) | 一种治疗慢性精神分裂症的中药 | |
| CN101028307A (zh) | 一种治疗肝腹水的中药 | |
| CN101011425A (zh) | 一种治疗食道癌、胃癌、子宫癌、子宫肌瘤的中药 | |
| CN101028293A (zh) | 一种治疗食道癌、胃癌、子宫癌的中药 | |
| CN101028296A (zh) | 一种治疗肿瘤的中药 | |
| CN101028300A (zh) | 一种治疗风湿性关节疼痛的中药 | |
| CN1723950A (zh) | 一种治疗高脂血症及其并发症的中药药物 | |
| CN1680532A (zh) | 一种功能型含酒精液体饮料的生产方法 | |
| CN101028295A (zh) | 一种治疗乙肝的中药 | |
| WO2017031658A1 (zh) | 一种抗肿瘤药物组合物及其制备方法 | |
| CN105214031A (zh) | 一种治疗消化性溃疡的水提物颗粒剂 | |
| CN102406861B (zh) | 一种治疗支气管炎的外敷药 | |
| CN101028294A (zh) | 一种治疗肝硬化的中药 | |
| CN102049030B (zh) | 一种治疗胃肠痛的中药组合物 | |
| CN101028303A (zh) | 一种治疗高血压的中药 | |
| CN101028299A (zh) | 一种治疗心脏病的中药 | |
| CN1162163C (zh) | 一种治疗风湿性关节炎的中草药酒 | |
| CN1403143A (zh) | 治疗胃肠疾病的组合物中药 | |
| CN101028308A (zh) | 一种治疗肿瘤的中药 | |
| CN106361970A (zh) | 一种用于治疗肺癌的中药 | |
| CN1660282A (zh) | 一种治疗乙型肝炎的药物组合物及其制备方法 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| EE01 | Entry into force of recordation of patent licensing contract |
Assignee: Beijing Tian Zhi Shen wild Ganoderma lucidum science and Technology Research Institute Assignor: Chen Kanglin Contract fulfillment period: 2007.11.6 to 2024.12.10 contract change Contract record no.: 2007990000093 Denomination of invention: Chinese medicine for treating liver hydroperitoneum Granted publication date: Wei Shouquan License type: Exclusive license, sub license Record date: 2007.12.3 |
|
| LIC | Patent licence contract for exploitation submitted for record |
Free format text: EXCLUSIVE LICENCE; TIME LIMIT OF IMPLEMENTING CONTACT: 2007.11.6 TO 2024.12.10 Name of requester: BEIJING TIAN-ZHI HUASHEN WILD GANODERMA LUCIDUM S Effective date: 20071203 |
|
| ASS | Succession or assignment of patent right |
Owner name: SHI HAIYAN Free format text: FORMER OWNER: CHEN KANGLIN Effective date: 20080718 |
|
| C41 | Transfer of patent application or patent right or utility model | ||
| TA01 | Transfer of patent application right |
Effective date of registration: 20080718 Address after: Room 717, B block, 27 international capital center, South Binhe Road, Beijing, Xuanwu District, China: 100055 Applicant after: Shi Haiyan Address before: 7, Liyuan villa, South long Kun Road, Hainan, Haikou Province, China: 570000 Applicant before: Chen Kanglin |
|
| C02 | Deemed withdrawal of patent application after publication (patent law 2001) | ||
| WD01 | Invention patent application deemed withdrawn after publication |